Antitumor efficacy of intermittent low-dose erlotinib plus sulindac via MHC upregulation and remodeling of the immune cell niche.
间歇性低剂量厄洛替尼联合舒林酸通过上调 MHC 和重塑免疫细胞微环境发挥抗肿瘤疗效
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.35409
Tripathi Chakrapani, Tovar Perez Jorge E, Kapoor Sabeeta, Muhsin Ahmed, Dashwood Wan Mohaiza, Demirhan Yunus, Demirhan Melek, Shapiro Alessandro, Mohammed Altaf, Sei Shizuko, Thompson Jacklyn, Zaheer Mahira, Sinha Krishna M, Brown Powel H, Savage Michelle I, Vilar Eduardo, Rajendran Praveen, Dashwood Roderick H
